Dr Mary Kerr, CEO of KaNDy Therapeutics to present at the 4th Annual Investival Showcase, hosted by LSX and Jefferies
The Investival Showcase in London is hosted by LSX and Jefferies and connects life science corporates with capital as part of Europe’s biggest health-dedicated investment week. During the showcase, CEO of KaNDy Therapeutics, Dr Mary Kerr, will be presenting the latest clinical developments from KaNDy’s NT-814 study, a potential breakthrough and non-hormonal alternative for symptoms of the menopause. View the full agenda here, https://bit.ly/2NYI4WQ